Blann, A.

perindopril patient study effect treatment europa baseline 1 year protein reduction enos protein expression europa study factor artery disease result ace inhibition apoptosi ang ii disease placebo event trial level expression value inhibition biomarker blood serum von willebrand factor artery control ceconi plasma group function atherosclerosi cad patients analysis heart pressure italy population research control group tnf -α nitric oxide synthase neurohormonal activation trial d-dimer investigator dysfunction heart failure activity fi brinogen diabetes infarction prognostic blood pressure 0.01 table brinogen huvec subject netherland institute signi comini l downloaded bradykinin thrombosis european trial athen coefficient increase angiotensin ii 87 cad patients necrosis 237–246 tumor necrosis factor-alpha inhibitor